tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NRSN Stock Latest News

NeuroSense Launches Pre-Funded Warrants Offering
Company AnnouncementsNeuroSense Launches Pre-Funded Warrants Offering
6d ago
6K
NRSN
NeuroSense Advances ALS Therapy with Promising Trials
PremiumCompany Announcements
NeuroSense Advances ALS Therapy with Promising Trials
8d ago
6K
NRSN
NeuroSense prices $4.5M registered direct offering at $1.50 per share
PremiumThe Fly
NeuroSense prices $4.5M registered direct offering at $1.50 per share
8d ago
NRSN
NeuroSense Partners with Lonza on ALS Biomarker Research
PremiumCompany Announcements
NeuroSense Partners with Lonza on ALS Biomarker Research
10d ago
6K
NRSN
NeuroSense, Lonza announce collaboration
PremiumThe Fly
NeuroSense, Lonza announce collaboration
10d ago
NRSN
NeuroSense’s Positive ALS Trial Results and 2023 Finances
PremiumCompany AnnouncementsNeuroSense’s Positive ALS Trial Results and 2023 Finances
14d ago
6K
NRSN
NeuroSense Announces Year End 2023 Financial Results and Provides Business Update
PremiumPress Releases
NeuroSense Announces Year End 2023 Financial Results and Provides Business Update
14d ago
NRSN
NeuroSense reports additional data from its Phase 2b PARADIGM trial of PrimeC
PremiumThe Fly
NeuroSense reports additional data from its Phase 2b PARADIGM trial of PrimeC
2M ago
NRSN
NeuroSense regains compliance with NASDAQ listing rules
PremiumThe Fly
NeuroSense regains compliance with NASDAQ listing rules
2M ago
NRSN
NeuroSense reports statistically significant efficacy in Phase 2b ALS Trial
PremiumThe Fly
NeuroSense reports statistically significant efficacy in Phase 2b ALS Trial
4M ago
BIIB
NRSN
NeuroSense’s Phase 2b ALS trial achieves safty and efficacy endpoints
PremiumThe Fly
NeuroSense’s Phase 2b ALS trial achieves safty and efficacy endpoints
5M ago
NRSN
NeuroSense Announces Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
NeuroSense Announces Third Quarter 2023 Financial Results and Provides Business Update
5M ago
NRSN
NeuroSense completes dosing in Phase 2b ALS clinical trial of PrimeC
PremiumThe FlyNeuroSense completes dosing in Phase 2b ALS clinical trial of PrimeC
5M ago
BIIB
NRSN
NeuroSense provides Q3 update
PremiumThe Fly
NeuroSense provides Q3 update
6M ago
NRSN
NeuroSense announces results of in vitro study of PrimeC in ALS
PremiumThe Fly
NeuroSense announces results of in vitro study of PrimeC in ALS
7M ago
NRSN
NeuroSense terminates prior ‘at-the-market’ equity offering program
PremiumThe Fly
NeuroSense terminates prior ‘at-the-market’ equity offering program
7M ago
NRSN
NeuroSense granted SME status by European Medicines Agency
PremiumThe Fly
NeuroSense granted SME status by European Medicines Agency
7M ago
NRSN
NeuroSense granted patents in Europe, Japan, and Israel for its ALS drug PrimeC
PremiumThe Fly
NeuroSense granted patents in Europe, Japan, and Israel for its ALS drug PrimeC
7M ago
NRSN
NeuroSense to hold an investor webinar
PremiumThe Fly
NeuroSense to hold an investor webinar
7M ago
NRSN
NeuroSense to hold an investor webinar
PremiumThe FlyNeuroSense to hold an investor webinar
7M ago
NRSN
NeuroSense to hold an investor webinar
PremiumThe Fly
NeuroSense to hold an investor webinar
7M ago
NRSN
NeuroSense Announces Second Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
NeuroSense Announces Second Quarter 2023 Financial Results and Provides Business Update
8M ago
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >